Ivan V. Pozhidaev

Tomsk, TOM 634014, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

NOS1AP Gene Polymorphism and Body Fat in Patients with Schizophrenia: A Search for Associations

NOS1AP Gene Polymorphism and Body Fat in Patients with Schizophrenia: A Search for Associations

Journal: Molekuliarnaia biologiia
Published: June 05, 2024

NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with Schizophrenia.

NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with Schizophrenia.

Journal: Biomedicines
Published: January 29, 2024

The Role of Glutamatergic Gene Polymorphisms in the Clinical Phenotypes of Schizophrenia.

The Role of Glutamatergic Gene Polymorphisms in the Clinical Phenotypes of Schizophrenia.

Journal: Genes
Published: February 03, 2023

The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.

The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.

Journal: Genes
Published: June 22, 2022

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia.

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia.

Journal: Diagnostics (Basel, Switzerland)
Published: May 26, 2022

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.

Journal: Genes
Published: April 09, 2022

Polymorphisms in the adrenergic neurotransmission pathway impact antidepressant response in depressed patients.

Polymorphisms in the adrenergic neurotransmission pathway impact antidepressant response in depressed patients.

Journal: Neuroscience applied
Published: December 24, 2021

Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients.

Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients.

Journal: Pharmacogenomics and personalized medicine
Published: July 01, 2021

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action.

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action.

Journal: Journal of personalized medicine
Published: June 23, 2021

Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design.

Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design.

Journal: Human psychopharmacology
Published: June 07, 2021

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia.

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia.

Journal: Journal of personalized medicine
Published: February 04, 2021

Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals.

Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals.

Journal: Frontiers in psychiatry
Published: February 03, 2021
Showing 1-12 of 27

Last Updated: 09/26/2026